India Monoclonal Antibodies Market Size, Share & Market Forecast FY2026

FY2016–FY2026 INDIA MONOCLONAL ANTIBODIES MARKET FORECAST & OPPORTUNITIES

www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING

Scope of Report Product of Interest (POI): Monoclonal Antibodies

Monoclonal antibodies are man-made proteins that act like human antibodies in the immune system. There are 4 different ways they can be made and are named based on what they are made of. Murine: These are made from mouse proteins and the names of the treatments end in -omab. Chimeric: These proteins are a combination of part mouse and part human and the names of the treatments end in -ximab. Humanized: These are made from small parts of mouse proteins attached to human proteins and the names of the treatments end in –zumab Human: These are fully human proteins and the names of the treatments end in –umab.

Market Segmentation MONOCLONAL ANTIBODIES MARKET

TYPE •

Murine

•

Chimeric

•

Humanized

•

Human

PRODUCTION •

In Vitro

•

In Vivo

END USERS •

Hospitals

•

Research Laboratories

•

Others

Year Range Review Period

FY2016 – FY2019 Base Year

APPLICATION

BIOMANUFACTURING

REGION

•

Cancer

•

Originator

•

North

•

Cardiac/Cardiovascular

•

CMO

•

South

•

Neurological

•

East

•

Others

•

West

FY2020 Estimated Year

FY2021 Forecast Period

FY2022 – FY2026

2

Table of Contents S. No. 1.

2.

3.

4.

5.

Contents

Page No.

Product Overview (A brief description of the category and product inclusions considered under the scope of the study to give clear picture to the client about the product of interest.)

Research Methodology (A brief description of the category and product inclusions considered under the scope of the study to give clear picture to the client about the product of interest.)

Executive Summary (This chapter covers summary of the complete study.)

Voice of Customer (Brand Awareness, Challenges Faced Post Purchase, Factors Influencing Purchase Decision) India Monoclonal Antibodies Market Outlook, FY2016-FY2026F (This chapter includes a brief overview of the product of interest market such as total market’s growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.)

5.1.

Market Size & Forecast 5.1.1.

5.2.

By Value (USD)

Market Share & Forecast (The overall product of interest bifurcated/split among various segments.)

5.2.1.

By Type (Murine, Chimeric, Humanized, Human)

5.2.2.

By Application (Cancer, Cardiac/Cardiovascular, Neurological, Others)

5.2.3.

By Production (In vitro, In vivo)

5.2.4.

By Biomanufacturing (Originator, CMO)

5.2.5.

By End users (Hospitals, Research Laboratories, Others)

5.2.6.

By Company (FY2020)

5.2.7.

By Region

5.3.

Product Market Map (By Type)

5.4.

Product Market Map (By Application)

5.5.

Product Market Map (By Region)

3

Table of Contents S. No.

Contents 5.3.

6.

Product Market Map (By Type, By Application, By Region)

India Cancer Monoclonal Antibodies Market Outlook, FY2016-FY2026F 6.1.

Market Size & Forecast 6.1.1.

6.2.

7.

By Value (USD)

Market Share & Forecast 6.2.1.

By Type

6.2.2.

By Production

6.2.3.

By End Users

India Cardiac/Cardiovascular Monoclonal Antibodies Market Outlook, FY2016-FY2026F 7.1.

Market Size & Forecast 7.1.1.

7.2.

8.

Page No.

By Value (USD)

Market Share & Forecast

7.2.1.

By Type

7.2.2.

By Production

7.2.3.

By End Users

India Neurological Monoclonal Antibodies Market Outlook, FY2016-FY2026F 8.1.

Market Size & Forecast 8.1.1.

8.2.

By Value (USD)

Market Share & Forecast 8.2.1.

By Type

8.2.2.

By Production

8.2.3.

By End Users

4

Table of Contents S. No. 9.

Contents

Page No.

Market Dynamics (This chapter assesses the major demand drivers and restraints.)

9.1.

Drivers

9.2.

Challenges

10.

Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)

11.

Impact of COVID-19 on India Monoclonal Antibodies Market

12.

Import Export Analysis

13.

Competitive Landscape 13.1.

Competition Outlook

13.2.

Company Profiles (Top 10 Leading Companies) 13.2.1. Company Details 13.2.2. Products & Services 13.2.3. Financials (As Reported) 13.2.4. Key Market Focus & Geographical Presence 13.2.5. Recent Developments 13.2.6. Key Management Personnel

14.

Strategic Recommendations

15.

About Us & Distributor

5

RESEARCH METHODOLOGY

Research Methodology

Market Profiling

In-depth secondary research was conducted to determine top players in the India monoclonal antibodies market, overall market size and segmental market size.

Formulating Questionnaire

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

Developing List of Respondents

List of industry players and industry specialists was developed.

Data Collection

Data Validation

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

TechSci conducted interviews with industry experts and industry players for data collection and verification.

Primary Research

Data Collection

Data Filter & Analysis

Research & Intelligence

Actionable Insights

Business Solution

Primary Research ✓ LinkedIn ✓ TechSci Internal Database

Desk Research

✓ Identifying Key Opinion Leaders ✓ Questionnaire Design ✓ In-depth Interviews

Secondary Research ✓ Company Websites ✓ Company Annual Reports ✓ White Paper Study ✓ Financial Reports ✓ Investor Presentations ✓ Regulatory Body ✓ Associations, etc.

✓ Recent Developments ✓ Market Changing Aspects/Dynamics ✓ Government Policies ✓ Conclusion

Data Analysis

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the India monoclonal antibodies market.

Company Analysis ✓ Market Participants ✓ Key Strengths

Paid Sources ✓ Factiva ✓ Hoovers

7

Research Methodology Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of India monoclonal antibodies market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in India monoclonal antibodies market.

Methodology Followed for Calculation of Market Size:

•

Market Size By Value : Market size, in terms of value, for the year FY2020 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as monoclonal antibodies companies, end users, industry experts, and other industry participants.

•

The team interviewed more than 40 – 50 companies, 180 – 200 end users, and 15 – 20 industry experts and other value chain stakeholders in the India monoclonal antibodies market to obtain the overall market size from FY2016 to FY2020, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during FY2016-FY2020.

•

Respondents were asked about the current and future market growth rates, market shares by type, by application, by production, by biomanufacturing, by end users, by region and by company. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.

8

Research Methodology Methodology Followed for Calculation of Market Shares: Market shares by type, by application, by production, by biomanufacturing, by end users, by region and by company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated

from various segments of monoclonal antibodies market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting: •

TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.

•

Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India monoclonal antibodies market, TechSci Research used various forecast techniques such as: ✓

Moving Average

✓

Time Series Analysis

✓

Regression Analysis

✓

Econometric and Judgmental Analysis

9

Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data.

Partial List of Companies Interviewed

Key Secondary Sources

▪ Novartis India Limited

▪ Biotech Research Society of India

▪ Johnson & Johnson Private Limited (JJPL)

▪ World Health Organization (WHO)

▪

Bristol Myers Squibb India Pvt. Ltd.

▪ Biotechnology Industry Research Assistance Council (BIRAC)

▪ Roche India Pvt. Ltd.

▪ Society of Biotechnology of India (BRSI)

▪ Amgen Technology Pvt. Ltd.

▪ All India Biotech Association (AIBA)

▪ Merck Limited

▪ World Bank

▪ Eli Lilly & Co (India) Pvt. Ltd.

▪ TechSci Research Proprietary Database & Knowledge

▪

Biocon Limited

Repository

▪ AstraZeneca Pharma India Limited

▪ Company Annual Reports

▪ Pfizer Ltd.

▪ Industry Magazines ▪ Industry Reports

▪ Statista ▪ News Dailies ▪ Credible Paid Databases

10

COMPETITIVE LANDSCAPE

Industry Brief According to TechSci Research report, “India Monoclonal Antibodies Market By Type (Murine, Chimeric, Humanized, Human), By Application (Cancer, Cardiac/Cardiovascular, Neurological, Others), By Production (In vitro, In vivo), By Biomanufacturing (Originator, CMO), By End Users (Hospitals, Research Laboratories, Others), By Region, Forecast & Opportunities, FY2026”, the India monoclonal antibodies market is expected to grow at a steady rate during the forecast period. Monoclonal antibodies are replicas of a unique parallel cell derived from identical immune cells. The antibodies can bind to a particular antigen as they have monovalent affinity. These antibodies serve as an important tool to detect and purify substances, thus have important end use in biochemistry, molecular biology, and medicine. Growth in demand for personalized medicines and surge in development of therapeutic antibodies is expected to drive the market for monoclonal antibodies through FY2026. Advantages of monoclonal antibodies such as homogeneity, specificity and large-scale production are expected to further boost its growth. The market for monoclonal antibodies is driven by persistent innovation in drug development and discovery and increasing incidences of chronic diseases. The emergence of advanced technologies and launch of innovative products in the biotechnology coupled with growth in the economy is helping in the market growth of monoclonal antibodies. Increasing R&D investment and ease in the availability of various resources used in the research centers are fueling the market growth in the country.

The India monoclonal antibodies market is segmented based on type, application, production, biomanufacturing, end users, company and region. Based on type, the murine segment is expected to dominate the market share in the forecast period. Increasing number of people suffering from various health disorders is the reason for the growth of this segment in the forecast period. Based on end users, hospitals segment is expected to dominate the market share in the forecast period due to increase in the number of hospitals and healthcare centers in the country. Besides, growing geriatric population is another factor for the growth of this segment.

Novartis International AG, Johnson & Johnson, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Amgen Inc., Merck & Co. Inc., Eli Lilly and Company, Biocon Limited, AstraZeneca PLC, Pfizer Inc. and others are some of the leading players operating in India monoclonal antibodies market. The companies operating in the market are using strategies such as product launches, mergers and collaborations to boost their share in the country.

“India monoclonal antibodies market is expected to register significant growth during the forecast period. The increased importance given to state infection control and management and the growing prevalence of lifestyle-related health issues are the key driving factors for the growth of monoclonal antibodies market in India. The market will continue to grow, owing to amplified public investments for research and technological developments in the country. Improvement in healthcare infrastructure is also one of the major factors for the growth of monoclonal antibodies market. The advancements in genomics research and development activities is expected to contribute to the market growth in the forecast period.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm. © TechSci Research

12

Sample Data - Snapshot India Monoclonal Antibodies Market Size, By Value (Million), FY2016–FY2026F 5.00

CAGR By Value

FY2016

9.00

10.00

FY2020

FY2021E

8.00

7.00

6.00

XX%

11.00

12.00

13.00

14.00

CAGR By Value

15.00

FY2026F

YY%

By Value (USD)

India Monoclonal Antibodies Market Share, By Type, By Value, FY2016–FY2026F Murine FY2026F FY2025F FY2024F FY2023F FY2022F FY2021E FY2020 FY2019 FY2018 FY2017 FY2016

Chimeric

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Humanized

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Human 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

India Cancer Monoclonal Antibodies Market Share, By Production, By

India Cancer Monoclonal Antibodies Market Share, By End Users, By

Value, FY2016–FY2026F In Vitro

Value, FY2016–FY2026F

FY2026F FY2025F FY2024F FY2023F FY2022F FY2021E FY2020 FY2019 FY2018 FY2017 FY2016 © TechSci Research

50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50%

In Vivo 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50%

Hospitals FY2026F FY2025F

FY2024F FY2023F FY2022F

FY2021E FY2020 FY2019

FY2018 FY2017 FY2016

33% 33% 33% 33% 33% 33% 33% 33% 33% 33% 33%

Research Laboratories 34% 34% 34% 34% 34% 34% 34% 34% 34% 34% 34%

Others 33% 33% 33% 33% 33% 33% 33% 33% 33% 33% 33%

13

Report Ordering

Report Name: INDIA MONOCLONAL ANTIBODIES MARKET FORECAST & OPPORTUNITIES FY2016–FY2026

Report Price License Type

Price

Electronic Access - Single User License

$2950

Electronic Access - Multi-User License

$3750

Custom Research License

$7500

To View Sample OR Purchase Report

© TechSci Research

14

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting

models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports •

Global Liver Cancer Therapeutics Market By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2026

•

United States Mobility Aid Medical Devices Market By Product (Wheelchairs, Walking Aids, Mobility Lifts, Slings, Tricycles, Mobility Scooters), By End User (Personal v/s Institutional), By Region, Competition, Forecast & Opportunities, FY 2026 TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia Pacific 54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia-Pacific

B – 44, Sector – 57, Noida, National Capital Region, U.P. - United States Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com

Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand.

However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.